WealthPLAN Partners’s Cascadian Therapeutics, Inc. CASC Stock Holding History

WealthPLAN Partners’s Portfolio CASC Stock Details CASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$2.8K	Sell	278 -277	-50%	-$1.96K	﹤0.01%	812
2016 Q2	$1.57K	Buy	+555	New	+$3.77K	﹤0.01%	2274
2015 Q4	$3.71K	Buy	+833	New	+$14.3K	﹤0.01%	1402
2015 Q2	$6K	Hold	278	–	–	﹤0.01%	337
2015 Q1	$2K	Buy	+278	New	+$2.73K	﹤0.01%	500

Other funds holding CASC

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return